Signal transduction by receptors with tyrosine kinase activity

Axel Ullrich(Max Planck Institute of Biochemistry), Joseph Schlessinger(Columbia University Irving Medical Center)
Cell
April 1, 1990
10.1016/0092-8674(90)90801-k
Cited by 5,517

Abstract

Related Papers

Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
Chao‐Kai Chou, Thomas J. Dull, David Russell et al.|Journal of Biological Chemistry|1987|649
Two Different Subunits Associate to Create Isoform-Specific Platelet-derived Growth Factor Receptors
Ronald A. Seifert, Charles E. Hart, Paul E. M. Phillips et al.|Journal of Biological Chemistry|1989|619
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
Donald A. McClain, Hiroshi Maegawa, J Lee et al.|Journal of Biological Chemistry|1987|405
Dimerization of B-type Platelet-derived Growth Factor Receptors Occurs After Ligand Binding and Is Closely Associated with Receptor Kinase Activation
Carl‐Henrik Heldin, A Ernlund, Charlotte Rorsman et al.|Journal of Biological Chemistry|1989|359
Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent.
Claude Cochet, O Kashles, E.M. Chambaz et al.|Journal of Biological Chemistry|1988|226